Torrance Nicola, Lawson Kenny D, Afolabi Ebenezer, Bennett Michael I, Serpell Michael G, Dunn Kate M, Smith Blair H
Medical Research Institute, University of Dundee, Dundee, Scotland, UK.
Centre for Research Excellence in the Prevention of Chronic Conditions in Rural and Remote Populations, James Cook University, Townsville City, Australia.
Pain. 2014 Oct;155(10):1996-2004. doi: 10.1016/j.pain.2014.07.001. Epub 2014 Jul 11.
The EQ-5D and Short Form (SF)12 are widely used generic health-related quality of life (HRQoL) questionnaires. They can be used to derive health utility index scores, on a scale where 0 is equivalent to death and 1 represents full health, with scores less than zero representing states "worse than death." We compared EQ-5D or SF-6D health utility index scores in patients with no chronic pain, and chronic pain with and without neuropathic characteristics (NC), and to explore their discriminant ability for pain severity. Self-reported health and chronic pain status was collected as part of a UK general population survey (n=4451). We found moderate agreement between individual dimensions of EQ-5D and SF-6D, with most highly correlated dimensions found for mental health and anxiety/depression, role limitations and usual activities, and pain and pain/discomfort. Overall 43% reported full health on the EQ-5D, compared with only 4.2% on the SF-6D. There were significant differences in mean utilities for chronic pain with NC (EQ-5D 0.47 vs SF-6D 0.62) and especially for severe pain (EQ-5D 0.33 vs SF-6D 0.58). On the EQ-5D, 17% of those with chronic pain with NC and 3% without NC scored "worse than death," a state which is not possible using the SF-6D. Health utilities derived from EQ-5D and SF-12/36 can discriminate between group differences for chronic pain with and without NC and greater pain severity. However, the instruments generate widely differing HRQoL scores for the same patient groups. The choice between using the EQ-5D or SF-6D matters greatly when estimating the burden of disease.
EQ-5D和简表(SF)12是广泛使用的与健康相关的通用生活质量(HRQoL)问卷。它们可用于得出健康效用指数得分,范围是0相当于死亡,1代表完全健康,得分低于零表示“比死亡更糟”的状态。我们比较了无慢性疼痛、有和无神经病理性特征(NC)的慢性疼痛患者的EQ-5D或SF-6D健康效用指数得分,并探讨它们对疼痛严重程度的判别能力。作为英国一般人群调查(n = 4451)的一部分,收集了自我报告的健康状况和慢性疼痛状态。我们发现EQ-5D和SF-6D的各个维度之间存在中度一致性,心理健康与焦虑/抑郁、角色限制与日常活动、疼痛与疼痛/不适等维度的相关性最高。总体而言,43%的人在EQ-5D上报告完全健康,而在SF-6D上只有4.2%。有NC的慢性疼痛患者的平均效用存在显著差异(EQ-5D为0.47,而SF-6D为0.62),尤其是重度疼痛患者(EQ-5D为0.33,而SF-6D为0.58)。在EQ-5D上,有NC的慢性疼痛患者中有17%以及无NC的患者中有3%的得分“比死亡更糟”,而使用SF-6D则不可能出现这种情况。从EQ-5D和SF-12/36得出的健康效用可以区分有无NC的慢性疼痛患者群体差异以及更严重的疼痛程度。然而,这些工具对同一患者群体得出的HRQoL得分差异很大。在估计疾病负担时,选择使用EQ-5D还是SF-6D至关重要。